ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.50
-0.72 (-2.75%)
Jul 13, 2026, 4:00 PM EDT - Market closed
ACADIA Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, ACADIA Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $32.65. The average 1-year stock price forecast is 28.04% higher than the current stock price, while the lowest is $17 (-33.33%) and the highest is $45 (+76.47%).
Price Target: $32.65 (+28.04%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 21 | 21 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $33 → $27 | Buy | Reiterates | $33 → $27 | +5.88% | Jul 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $29 → $36 | Buy | Maintains | $29 → $36 | +41.18% | Jul 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $29 → $30 | Buy | Reiterates | $29 → $30 | +17.65% | Jun 30, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $32 → $37 | Buy | Maintains | $32 → $37 | +45.10% | Jun 29, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $32 → $36 | Buy | Reiterates | $32 → $36 | +41.18% | Jun 29, 2026 |
Financial Forecast
Revenue This Year
1.24B
from 1.07B
Increased by 15.80%
Revenue Next Year
1.40B
from 1.24B
Increased by 12.44%
EPS This Year
0.38
from 0.83
Decreased by -54.04%
EPS Next Year
0.89
from 0.38
Increased by 133.58%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.3B | ||
| Avg | 1.2B | ||
| Low | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.9% | ||
| Avg | 15.8% | ||
| Low | 14.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.74 | ||
| Avg | 0.38 | ||
| Low | 0.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -10.8% | ||
| Avg | -54.0% | ||
| Low | -72.3% |